Abevmy 400mg (mylan) | Bevacizumab | MHP
ABEVMY 400MG/16ML NON-SQUAMOUS DESCRIPTION Bevacizumab is a drug sold under the name of Abevmy 400mg and which is categorized as monoclonal anti-body & anti-angiogenesis When Abevmy 400mg concomitant use with human monoclonal antibody IgG1, that circumstance and prohibits the biological action of human vascular endothelial growth factor (VEGF). USAGE Abevmy 100mg is indicated for the treatment of some of the conditions like : Metastatic colon or rectal cancer Non-squamous, non-small cell lung cancer Glioblastoma Metastatic renal cell cancer Metastatic cervical cancer Epithelial ovarian, fallopian tube or peritoneal cancer. MECHANISM OF ACTION Abevmy 400mg Injection comprises an active compound like Bevacizumab which binds to VEGF and avoid the communication of VEGF to its receptors like Flt-1 & KDR) present on the surface of the cells This interaction prevents endothelial cell multiplication and new blood vessel p...